STK32B (serine/threonine kinase 32B) encodes a member of the STK32/YANK serine-threonine kinase family and functions as a protein kinase capable of phosphorylating serine and threonine residues, although its physiological substrates and downstream signaling mechanisms remain incompletely defined
[1][2]. As part of the AGC kinase-related STK32 family, STK32B shares structural features with the closely related paralogs STK32A and STK32C, yet current evidence indicates distinct tissue-specific expression and disease associations among these isoforms
[3][2]. Mechanistically, available transcriptomic studies suggest that altered STK32B expression influences biological processes linked to axon guidance, calcium ion transmembrane transport, and olfactory signaling, supporting a role in neuronal regulatory networks
[4]. Disease relevance is most strongly supported in essential tremor (ET), where genome-wide association analyses identified variants within the STK32B locus and demonstrated increased STK32B expression in the cerebellar cortex of affected individuals
[5]. Consistent with these genetic observations, experimental overexpression of STK32B in human cerebellar DAOY cells induced transcriptomic alterations affecting ET-associated genes, including FUS, and enriched pathways related to neuronal signaling and calcium channel biology
[4]. Compared with related STK32 family members, STK32B has been more directly linked to ET susceptibility and cerebellar molecular phenotypes, making it a useful target for mechanistic studies of movement disorders
[5][4]. Currently, no widely established selective STK32B agonists or inhibitors have been reported in the cited literature, and functional investigation primarily relies on genetic, transcriptomic, and cellular overexpression models
[4][3].